What We're Reading: Page 195
Industry reads hand-picked by our editors
May 11, 2020
-
The New York Times
U.S. to Accuse China of Trying to Hack Vaccine Data, as Virus Redirects Cyberattacks
-
The Wall Street Journal
Amazon, Berkshire, JPMorgan Health-Care Venture Looking for New CEO
-
Reuters
Pfizer to outsource some drug production, focus on coronavirus vaccine
-
Financial Times
Paris, Texas, offers a cautionary tale on reopening America
May 07, 2020
-
STAT
Doctors lambaste process for distributing Covid-19 drug remdesivir
-
The Atlantic
The Problem With Stories About Dangerous Coronavirus Mutations
-
Endpoints News
Tetraphase has two suitors, despite struggling market for antibiotics
-
Reuters
Japan approves Gilead Sciences' remdesivir as COVID-19 drug
May 06, 2020
May 05, 2020
-
National Geographic
Fauci: No scientific evidence the coronavirus was made in a Chinese lab
-
STAT
Were researchers wrong to move the goalposts on remdesivir?
-
Axios
Antibiotic pipeline in peril from coronavirus and incentives system
-
Reuters
Bangladesh's Beximco to begin producing COVID-19 drug remdesivir - COO
May 04, 2020
May 01, 2020
-
The New York Times
Old Drugs May Find a New Purpose: Fighting the Coronavirus
-
BioCentury
India emerging as major COVID-19 vaccine manufacturer
-
STAT
Infect volunteers with Covid-19? A proposal lays bare a minefield of issues
-
MIT Technology Review
What if immunity to covid-19 doesn’t last?
Previous
